Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG: 3613)

Beijing Tong Ren Tang Chinese Medicine Company Statistics

Total Valuation

Beijing Tong Ren Tang Chinese Medicine Company has a market cap or net worth of HKD 6.98 billion. The enterprise value is 5.49 billion.

Market Cap	6.98B
Enterprise Value	5.49B

Important Dates

The next estimated earnings date is Thursday, March 13, 2025.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	Jun 12, 2024

Share Statistics

Beijing Tong Ren Tang Chinese Medicine Company has 837.10 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	837.10M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	7.47%
Float	237.04M

Valuation Ratios

The trailing PE ratio is 14.13 and the forward PE ratio is 11.05.

PE Ratio	14.13
Forward PE	11.05
PS Ratio	5.07
PB Ratio	1.83
P/TBV Ratio	1.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.77, with an EV/FCF ratio of -14.30.

EV / Earnings	11.10
EV / Sales	3.98
EV / EBITDA	8.77
EV / EBIT	10.10
EV / FCF	-14.30

Financial Position

The company has a current ratio of 16.79, with a Debt / Equity ratio of 0.03.

Current Ratio	16.79
Quick Ratio	9.48
Debt / Equity	0.03
Debt / EBITDA	0.21
Debt / FCF	-0.35
Interest Coverage	84.43

Financial Efficiency

Return on equity (ROE) is 13.83% and return on invested capital (ROIC) is 8.64%.

Return on Equity (ROE)	13.83%
Return on Assets (ROA)	8.22%
Return on Capital (ROIC)	8.64%
Revenue Per Employee	1.77M
Profits Per Employee	634,320
Employee Count	798
Asset Turnover	0.33
Inventory Turnover	0.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.70% in the last 52 weeks. The beta is 0.41, so Beijing Tong Ren Tang Chinese Medicine Company's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-35.70%
50-Day Moving Average	8.37
200-Day Moving Average	8.87
Relative Strength Index (RSI)	52.99
Average Volume (20 Days)	1,239,718

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Beijing Tong Ren Tang Chinese Medicine Company had revenue of HKD 1.38 billion and earned 494.14 million in profits. Earnings per share was 0.59.

Revenue	1.38B
Gross Profit	991.96M
Operating Income	551.14M
Pretax Income	617.46M
Net Income	494.14M
EBITDA	568.07M
EBIT	551.14M
Earnings Per Share (EPS)	0.59

Balance Sheet

The company has 1.79 billion in cash and 133.97 million in debt, giving a net cash position of 1.66 billion or 1.98 per share.

Cash & Cash Equivalents	1.79B
Total Debt	133.97M
Net Cash	1.66B
Net Cash Per Share	1.98
Equity (Book Value)	3.97B
Book Value Per Share	4.55
Working Capital	3.49B

Cash Flow

In the last 12 months, operating cash flow was -357.57 million and capital expenditures -26.06 million, giving a free cash flow of -383.63 million.

Operating Cash Flow	-357.57M
Capital Expenditures	-26.06M
Free Cash Flow	-383.63M
FCF Per Share	-0.46

Margins

Gross margin is 72.06%, with operating and profit margins of 40.03% and 35.89%.

Gross Margin	72.06%
Operating Margin	40.03%
Pretax Margin	44.85%
Profit Margin	35.89%
EBITDA Margin	41.26%
EBIT Margin	40.03%
FCF Margin	-27.87%

Dividends & Yields

This stock pays an annual dividend of 0.33, which amounts to a dividend yield of 3.96%.

Dividend Per Share	0.33
Dividend Yield	3.96%
Dividend Growth (YoY)	-43.10%
Years of Dividend Growth	n/a
Payout Ratio	55.90%
Buyback Yield	n/a
Shareholder Yield	3.96%
Earnings Yield	7.08%
FCF Yield	-5.49%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Beijing Tong Ren Tang Chinese Medicine Company has an Altman Z-Score of 21.21.

Altman Z-Score	21.21
Piotroski F-Score	n/a